G160(P) The use of aciclovir in the management of paediatric encephalitis: a multi-centre audit. (May 2019)

• Record Type: Journal Article
• Authors: Simons, E; Omar, S; Holt, A; Shelley, K; Nijjar, I; Sherlaw, C; Mills, R
• Is Part Of: Archives of disease in childhood. Volume 104:(2019)Supplement 2
• Page Start: A65
• Page End: A65
• Publication Date: 2019-05
• Subjects: Children -- Diseases -- Periodicals; Infants -- Diseases -- Periodicals; 618.920005
• DOI: 10.1136/archdischild-2019-rcpch.156
• Languages: English
• ISSNs: 0003-9888

Abstract

Abstract : Background: Encephalitis is a rare but serious childhood condition with potentially devastating morbidity. Early treatment of encephalitis is crucial to improve outcome. As encephalitis presents with non-specific symptoms common to the paediatric population identifying cases early can be challenging. There are multiple published reviews on the management of paediatric encephalitis, but the impact of these on everyday clinical practice is unclear. Aims: We aimed to investigate if children in our region with suspected encephalitis were managed in accordance with the national guideline (The Encephalitis Society: Management of Suspected Viral Encephalitis in Children. Professional Guidelines. 2012). Methods: Data was collected prospectively over a six month period from patient records of children (aged 0–17 years) commenced on intravenous Aciclovir for the treatment of suspected encephalitis at six District General Hospitals. Variables evaluated included presenting symptoms, investigations undertaken, length of treatment and rationale for stopping treatment. Results: 67 children met the inclusion criteria. The most common presenting features were fever (55%), generalised seizures (48%) and abnormal behaviour (48%). The average time from admission to commencing Aciclovir was 4.9 hours with 74% of patients receiving Aciclovir within 6 hours of admission. Average total duration of intravenous Aciclovir was 3.2 days. Lumbar puncture was attempted in 76% of cases, of which 88% were successful. 2 CSF cultures were positive for Neisseria Meningitidis and one CSF was PCR positive for Enterovirus. Nine children (13%) had a discharge diagnosis of encephalitis. Seizures were a common discharge diagnosis; 37% of children were diagnosed with either status epilepticus, a seizure disorder or febrile convulsions. National guidelines recommend that all children treated for suspected encephalitis should have an HIV test; none of our children had one conducted. Conclusion: Our study highlights the difficultly of diagnosing encephalitis in children and identifies wide regional variation in its management and poor adherence to national guidance.